Golden Year for European Nephrology. The Fiftieth European Renal Association - European Dialysis and Transplant Association Congress
Citas
De Zeeuw D, Coll B, Andress D, Brennan JJ, Tang H, Houser M, et al. The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy. J Am Soc Nephrol. 2014;25(5):1083-93.
Gupta A. Soluble Ferric Pyrophosphate (SFP) administered via hemodialysate reduces ESA Use. ERA-EDTA Congress (50th : Estambul, Turquía : 18-21 mayo 2013).
Floege J. Safety and efficacy of PA21, a novel iron-based phosphate binder, in patients with ESRD and hyperphosphatemia: long-term results. ERA-EDTA Congress (50th : Estambul, Turquía : 18-21 mayo 2013).
Striker, GE. Restoration of repressed estrogen receptor A (ERα) and anti-oxidant levels in women and men with diabetic kidney disease (DKD): possible cardiovascular disease (CVD) benefits. ERA-EDTA Congress (50th : Estambul, Turquía : 18-21 mayo 2013).
Fouqe D. Efficacy Of eculizumab In Atypical Hemolytic Uremic Syndrome (aHUS) patients with or without prior transplant. ERA-EDTA Congress (50th : Estambul, Turquía : 18-21 mayo 2013).
Hecking M. Gender-associated differences in dialysis patients. ERA-EDTA Congress (50th : Estambul, Turquía : 18-21 mayo 2013).
EVOLVE Trial Investigators, Chertow GM, Block GA, Correa-Rotter R, Drüeke TB, Floege J, et al. Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med. 2012;367(26):2482-94.
Floege J. Effect of cinacalcet use on all-cause mortality: parallel analyses in ARO incident observational european hemodialysis population and in EVOLVE Trial. ERA-EDTA Congress (50th : Estambul, Turquía : 18-21 mayo 2013).
Wang A. Oral Paricalcitol treatment on left ventricular mass and function in chronic kidney disease patients with cardiac hypertrophy (OPERA Study): a randomized controlled trial. ERA-EDTA Congress (50th : Estambul, Turquía : 18-21 mayo 2013).
Cannata-Andia JB. The use of PTH lowering drugs is associated with improved survival in hemodialysis patients: results from COSMOS. ERA-EDTA Congress (50th : Estambul, Turquía : 18-21 mayo 2013).
März W. Prognostic effect of high density lipoprotein cholesterol and apolipoproteins A1, A2 and C3 in diabetic patients on hemodialysis. ERA-EDTA Congress (50th : Estambul, Turquía : 18-21 mayo 2013).
